The coronavirus outbreak is still progressing and its full health and economic impacts are clearly not yet apparent. We expect to have more clarity over the next few months, but there is a high degree of uncertainty.
We are hopeful the global health authorities can contain this outbreak. China took extraordinary efforts, including shutting down travel and quarantining an entire province. Its response has been much faster than in past epidemics emanating from its shores. There has also been global cooperation and progress among medical experts studying the virus. Our hearts and thoughts are with the families of victims, those infected, and those battling the spread of the disease.
The spread in China seems to have meaningfully declined, with daily cases having peaked earlier in February. Concerns now turn toward the spread outside of China. The virus has broken quarantine and is spreading notably in Korea, Europe, and here in northern California, which hits close to home for many of us. We are all affected by the personal fears we have for family, friends, and ourselves. The uncertainty surrounding the medical implications of the virus is unsettling, but we will continue to watch and learn more as the medical research progresses.
In terms of the economic impact, it now seems likely the coronavirus—and the global containment measures in response to it—will have a larger negative shorter-term impact on the global economy than our base case a month ago. We can’t rule out the potential for the virus to trigger an economic recession, even if the odds are still low. But assuming this doesn’t escalate further and turn into a severe global pandemic, the effect on the global economy seems likely to be relatively short-lived—maybe a one or two quarter hit, followed by a make-up period of several quarters of above-normal growth. It is unlikely to have a lasting, long-term effect on the global economy, but it would cause a delay in the current nascent global recovery.
In terms of the financial market impact, history suggests that equity markets should start to rebound once the global rate of daily new virus cases peaks and starts to decline. That said, there could be more downside. If the virus news gets worse, it could lead to a sharper short-term drop in stocks and even a bear market. While the markets have been falling in February with great speed, it’s important to remember that U.S. stocks were up more than 3% year to date at the peak in February and up over 30% last year. That is the unusual occurrence, not the recent price correction, which is quite common historically. It is relatively normal to see 10%–15% declines in the stock market; they happen about once a year. Furthermore, our portfolios were already prepared and positioned for the possibility of stock market volatility before the coronavirus, with our overall equity underweight and our allocations to defensive and lower-risk asset classes.
Although we had been assuming a potential correction or bear market within our five-year market projections, it’s unfortunate this is coming from the virus. We have often said we didn’t know what could cause volatility—and we don’t need to predict it. It could have easily been one of the many other risk factors—trade wars, political uncertainty—not to mention the very high U.S. stock valuations coming into 2020. We must accept frequent and sometimes steep declines as equity investors to earn long-term returns.
Tactically, it’s not prudent to try to sidestep a market decline or a recession based on a prediction that is very difficult to get right. Instead, as valuation-based investors, we view large declines as opportunities to add back to stocks at attractive prices. If the correction continues, while it may be uncomfortable, we will be assessing whether it makes sense to increase our portfolio allocations to stocks, which we know can pay off handsomely for investors who stick to their discipline through volatile market environments.
Bottom line: Based on what we currently know, we do not believe this event changes our medium- to longer-term scenarios nor the key underlying assumptions for our expected return estimates for stocks and bonds. Therefore, we are not making any portfolio changes in response to the coronavirus at present. Markets have successfully weathered several outbreaks in the past, including SARS, MERS, swine flu, and bird flu. During most of these, the stock market generated a decent return in the 12 months after the outbreak. However, we continue to follow daily reporting on the trajectory and spread of the virus and other developments. If the facts and circumstances change, our analysis and views on the economic and portfolio impact may change as well.
If you have further questions or would like to discuss your individual situation and investment objectives, we encourage you to contact your Litman Gregory Advisor.
—Litman Gregory Investment Team (2/28/20)
A Decade Past, the Decade to Come
The last decade has seen U.S. stocks significantly outperform non-U.S. stocks, large caps outperform small caps, and growth strongly outperform value. And while the dominance of these trends has been unrelenting, we have already begun to see the last decade’s major market trends starting to reverse. In this post, we look back on the last 10 years and consider what to expect as investors over the next 10.
Litman Gregory Joins iM Global Partner
We would like to share some important and exciting news about our company’s future. After much due diligence and careful thought, the firm’s principals and founders have decided to take a significant step toward growing our resources and ensuring our ability to excel for generations to come by joining iM Global Partner, a privately held global investment services firm.